Boehringer Ingelheim Names New Board Member for IT
Boehringer Ingelheim announces Harsha Deshmukh's appointment to Board of Managing Directors for IT and Global Business Services effective February 2026.
Category : Search result: Boehringer Ingelheim
EU Backs Two New Avian Influenza Vaccines
Boehringer Ingelheim receives positive EU opinions for two innovative avian influenza vaccines, VAXXITEK® and VAXXINACT®, marking a major step in poultry disease control and outbreak preparedness.
Boehringer Ingelheim Licenses Novel Autoimmune Treatment
Global pharmaceutical leader Boehringer Ingelheim secures exclusive license from Kyowa Kirin to develop innovative autoimmune disease treatment, targeting conditions like lupus and rheumatoid arthritis with novel therapeutic approach.
Page 1 of 1